Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,158) with videos related to
Page
of 116
Sort By:
Annals of the American Thoracic Society
|
October 30, 2023
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report
Milica Vukmirovic, Kambez H Benam, Jason J Rose, et al.
Acta Neuropathologica Communications
|
June 9, 2018
The genetic landscape of ganglioglioma
Melike Pekmezci, Javier E Villanueva-Meyer, Benjamin Goode, et al.
Respiratory Research
|
March 29, 2020
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
Toby M Maher, Juliet K Simpson, Joanna C Porter, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis
Joseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
Communications Biology
|
March 24, 2021
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
Ryan S Dhindsa, Johan Mattsson, Abhishek Nag, et al.
Nature Communications
|
January 4, 2019
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Hannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
BMJ Open Respiratory Research
|
April 9, 2026
Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseases
Punchalee Kaenmuang, Joseph L Barnett, Toby M Maher, et al.
The Lancet. Respiratory Medicine
|
May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
Aitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Oncotarget
|
May 4, 2017
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis
Franco Conforti, Elizabeth R Davies, Claire J Calderwood, et al.
Blood
|
September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation
V Ratanatharathorn, R A Nash, D Przepiorka, et al.
Page
of 116
Search research articles
Search
Showing results (1101-1110 of 1,158) with videos related to
Sort By:
Page
of 116
Annals of the American Thoracic Society
|
October 30, 2023
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report
Milica Vukmirovic, Kambez H Benam, Jason J Rose, et al.
Acta Neuropathologica Communications
|
June 9, 2018
The genetic landscape of ganglioglioma
Melike Pekmezci, Javier E Villanueva-Meyer, Benjamin Goode, et al.
Respiratory Research
|
March 29, 2020
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
Toby M Maher, Juliet K Simpson, Joanna C Porter, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis
Joseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
Communications Biology
|
March 24, 2021
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
Ryan S Dhindsa, Johan Mattsson, Abhishek Nag, et al.
Nature Communications
|
January 4, 2019
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Hannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
BMJ Open Respiratory Research
|
April 9, 2026
Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseases
Punchalee Kaenmuang, Joseph L Barnett, Toby M Maher, et al.
The Lancet. Respiratory Medicine
|
May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
Aitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Oncotarget
|
May 4, 2017
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis
Franco Conforti, Elizabeth R Davies, Claire J Calderwood, et al.
Blood
|
September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation
V Ratanatharathorn, R A Nash, D Przepiorka, et al.
Page
of 116